Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

DTIL

PRECISION BIOSCIENCES INC

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • DTILPrecision Biologics, Inc
    0Calm

    Study of NEO-201 in Solid Tumors Expansion Cohorts

    Running, no new patientsPhase 1/2121 patientsMain results: Jun 17, 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 3 purchases

  • Frankel StanleyBoard member · Sep 28, 2026Bought 1,000 sharesabout $6 thousand ·
  • Brown MelindaBoard member · Sep 25, 2026Bought 1,135 sharesabout $7 thousand ·
  • Germano Geno JBoard member · Sep 25, 2026Bought 2,609 sharesabout $16 thousand ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Other newsNews report (8-K)Nov 9, 2026
  • Other newsNews report (8-K)Nov 6, 2026
  • New shares being soldNew shares being sold (424B5)Nov 6, 2026
  • Shared information with investors; Other newsNews report (8-K)Nov 5, 2026
  • Shared quarterly resultsNews report (8-K)Nov 3, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Quarterly reportQuarterly report (10-Q)
Nov 3, 2026
  • Shared information with investors; Other newsNews report (8-K)Aug 24, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • Shared quarterly resultsNews report (8-K)Aug 6, 2026
  • An executive or board member joined or left; Shared information with investorsNews report (8-K)Jul 27, 2026
  • Shared information with investors; Other newsNews report (8-K)Jul 1, 2026
  • Signed a major agreementNews report (8-K)Jun 16, 2026
  • Shared information with investors; Other newsNews report (8-K)May 27, 2026
  • An executive or board member joined or leftNews report (8-K)May 26, 2026